ArticleO&G open2024
A Gender-Affirming Approach to Fertility Care for Transgender and Gender-Diverse Patients.
Article in O&G open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Fertility preservation: is there a model for gender-dysphoric youth?Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although many transgender and gender-diverse (TGD) people express a desire to become parents, providing quality counseling that encompasses patients' short-term and long-term fertility options often represents a challenge for health care professionals. Fertility care (from preservation to restoration or assisted reproduction or both) has a low uptake in the TGD population, with barriers including financial cost, concerns regarding health care professionals' biases, and patient misconceptions or lack of awareness of fertility outcomes. Fertility care is particularly important for the TGD population, because gender-affirming hormone therapy can negatively affect fertility. Despite this importance, existing guidelines and research on this subject are limited. This article summarizes the currently available fertility care options for TGD patients and provides our clinical opinion on their best provision. We highlight that it is essential for health care professionals to provide TGD patients with holistic counseling to facilitate informed decision making about their reproductive health before initiating gender-affirming therapy. Fertility counseling should outline the options available for the patient, keeping their needs and preferences at the center of the conversation while advising on the associated risks and financial costs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.